These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15667428)

  • 61. A Load to Find Clinically Useful Biomarkers for Depression.
    Nikolac Perkovic M; Sagud M; Tudor L; Konjevod M; Svob Strac D; Pivac N
    Adv Exp Med Biol; 2021; 1305():175-202. PubMed ID: 33834401
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dysregulation of brain dopamine systems in major depressive disorder.
    Delva NC; Stanwood GD
    Exp Biol Med (Maywood); 2021 May; 246(9):1084-1093. PubMed ID: 33593109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dopamine System Dysregulation in Major Depressive Disorders.
    Belujon P; Grace AA
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1036-1046. PubMed ID: 29106542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Melancholic depression; clinical and therapeutic study].
    BERTAGNA L
    Rev Prat; 1957 May; 7(15):1651-4; passim. PubMed ID: 13442410
    [No Abstract]   [Full Text] [Related]  

  • 65. The involvement of serotonin in major depression: nescience in disguise?
    Arnone D; Wise T; Fitzgerald PB; Harmer CJ
    Mol Psychiatry; 2024 Jan; 29(1):200-202. PubMed ID: 38374356
    [No Abstract]   [Full Text] [Related]  

  • 66. Peripheral Markers of Depression.
    Nobis A; Zalewski D; Waszkiewicz N
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems.
    Camacho MB; Vijitbenjaronk WD; Anastasio TJ
    Front Pharmacol; 2019; 10():1215. PubMed ID: 31708770
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation.
    Camacho MB; Anastasio TJ
    Front Pharmacol; 2017; 8():925. PubMed ID: 29375372
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Evolutionary Theory of Depression.
    Gałecki P; Talarowska M
    Med Sci Monit; 2017 May; 23():2267-2274. PubMed ID: 28500855
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study.
    Mocking RJ; Figueroa CA; Rive MM; Geugies H; Servaas MN; Assies J; Koeter MW; Vaz FM; Wichers M; van Straalen JP; de Raedt R; Bockting CL; Harmer CJ; Schene AH; Ruhé HG
    BMJ Open; 2016 Mar; 6(3):e009510. PubMed ID: 26932139
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How Can We Predict Treatment Outcome for Depression?
    Walter M; Lord A
    EBioMedicine; 2015 Jan; 2(1):9-10. PubMed ID: 26137527
    [No Abstract]   [Full Text] [Related]  

  • 72. Heterogeneity in the prognosis of major depression: from the common cold to a highly debilitating and recurrent illness.
    Lorenzo-Luaces L
    Epidemiol Psychiatr Sci; 2015 Dec; 24(6):466-72. PubMed ID: 26081748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The functional anatomy of psychomotor disturbances in major depressive disorder.
    Liberg B; Rahm C
    Front Psychiatry; 2015; 6():34. PubMed ID: 25806006
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Melancholic-Like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice.
    Comai S; Ochoa-Sanchez R; Dominguez-Lopez S; Bambico FR; Gobbi G
    Int J Neuropsychopharmacol; 2015 Jan; 18(3):. PubMed ID: 25638817
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Visual perception during mirror-gazing at one's own face in patients with depression.
    Caputo GB; Bortolomasi M; Ferrucci R; Giacopuzzi M; Priori A; Zago S
    ScientificWorldJournal; 2014; 2014():946851. PubMed ID: 25506077
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality.
    Kemp AH; Quintana DS; Quinn CR; Hopkinson P; Harris AW
    Front Psychol; 2014; 5():1387. PubMed ID: 25505893
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway.
    Zhu H; Bogdanov MB; Boyle SH; Matson W; Sharma S; Matson S; Churchill E; Fiehn O; Rush JA; Krishnan RR; Pickering E; Delnomdedieu M; Kaddurah-Daouk R;
    PLoS One; 2013; 8(7):e68283. PubMed ID: 23874572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.
    Kaddurah-Daouk R; Bogdanov MB; Wikoff WR; Zhu H; Boyle SH; Churchill E; Wang Z; Rush AJ; Krishnan RR; Pickering E; Delnomdedieu M; Fiehn O
    Transl Psychiatry; 2013 Jan; 3(1):e223. PubMed ID: 23340506
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.
    Kaddurah-Daouk R; Boyle SH; Matson W; Sharma S; Matson S; Zhu H; Bogdanov MB; Churchill E; Krishnan RR; Rush AJ; Pickering E; Delnomdedieu M
    Transl Psychiatry; 2011; 1(7):e26-. PubMed ID: 22162828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Does psychomotor retardation define a clinically relevant phenotype of unipolar depression?
    Calugi S; Cassano GB; Litta A; Rucci P; Benvenuti A; Miniati M; Lattanzi L; Mantua V; Lombardi V; Fagiolini A; Frank E
    J Affect Disord; 2011 Mar; 129(1-3):296-300. PubMed ID: 20833434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.